Literature DB >> 12881317

Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).

Brunangelo Falini1, Enrico Tiacci, Alessandra Pucciarini, Barbara Bigerna, Julia Kurth, Georgia Hatzivassiliou, Sara Droetto, Barbara Verducci Galletti, Marcello Gambacorta, Attilio Orazi, Laura Pasqualucci, Ira Miller, Ralf Kuppers, Riccardo Dalla-Favera, Giorgio Cattoretti.   

Abstract

IRTA1 (immunoglobulin superfamily receptor translocation-associated 1) is a novel surface B-cell receptor related to Fc receptors, inhibitory receptor superfamily (IRS), and cell adhesion molecule (CAM) family members and we mapped for the first time its distribution in human lymphoid tissues, using newly generated specific antibodies. IRTA1 was selectively and consistently expressed by a B-cell population located underneath and within the tonsil epithelium and dome epithelium of Peyer patches (regarded as the anatomic equivalents of marginal zone). Similarly, in mucosa-associated lymphoid tissue (MALT) lymphomas IRTA1 was mainly expressed by tumor cells involved in lympho-epithelial lesions. In contrast, no or a low number of IRTA1+ cells was usually observed in the marginal zone of mesenteric lymph nodes and spleen. Interestingly, monocytoid B cells in reactive lymph nodes were strongly IRTA1+. Tonsil IRTA1+ cells expressed the memory B-cell marker CD27 but not mantle cell-, germinal center-, and plasma cell-associated molecules. Polymerase chain reaction (PCR) analysis of single tonsil IRTA1+ cells showed they represent a mixed B-cell population carrying mostly mutated, but also unmutated, IgV genes. The immunohistochemical finding in the tonsil epithelial areas of aggregates of IRTA1+ B cells closely adjacent to plasma cells surrounding small vessels suggests antigen-triggered in situ proliferation/differentiation of memory IRTA1+ cells into plasma cells. Collectively, these results suggest a role of IRTA1 in the immune function of B cells within epithelia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881317     DOI: 10.1182/blood-2003-03-0750

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.

Authors:  Edgar D Charles; Claudia Brunetti; Svetlana Marukian; Kimberly D Ritola; Andrew H Talal; Kristen Marks; Ira M Jacobson; Charles M Rice; Lynn B Dustin
Journal:  Blood       Date:  2011-03-18       Impact factor: 22.113

Review 2.  Phenotypic and functional heterogeneity of human memory B cells.

Authors:  Iñaki Sanz; Chungwen Wei; F Eun-Hyung Lee; Jennifer Anolik
Journal:  Semin Immunol       Date:  2008-02-06       Impact factor: 11.130

Review 3.  Mantle cell lymphoma.

Authors:  Stefano A Pileri; Brunangelo Falini
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

4.  Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma--combined performance of multiple markers.

Authors:  Michiel van den Brand; Janneke J M Mathijssen; Mar Garcia-Garcia; Konnie M Hebeda; Patricia J T A Groenen; Brunangelo Falini; Sergio Serrano; J Han J M van Krieken
Journal:  Haematologica       Date:  2015-06-11       Impact factor: 9.941

5.  The majority of human memory B cells recognizing RhD and tetanus resides in IgM+ B cells.

Authors:  Luciana Della Valle; Serge E Dohmen; Onno J H M Verhagen; Magdalena A Berkowska; Gestur Vidarsson; C Ellen van der Schoot
Journal:  J Immunol       Date:  2014-06-25       Impact factor: 5.422

Review 6.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

7.  Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation.

Authors:  James W Austin; Clarisa M Buckner; Lela Kardava; Wei Wang; Xiaozhen Zhang; Valerie A Melson; Ryan G Swanson; Andrew J Martins; Julian Q Zhou; Kenneth B Hoehn; J Nicholas Fisk; Yiannis Dimopoulos; Alexander Chassiakos; Sijy O'Dell; Margery G Smelkinson; Catherine A Seamon; Richard W Kwan; Michael C Sneller; Stefania Pittaluga; Nicole A Doria-Rose; Adrian McDermott; Yuxing Li; Tae-Wook Chun; Steven H Kleinstein; John S Tsang; Constantinos Petrovas; Susan Moir
Journal:  Sci Transl Med       Date:  2019-11-27       Impact factor: 17.956

8.  The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Authors:  Gotz R A Ehrhardt; Randall S Davis; Joyce T Hsu; Chuen-Miin Leu; Annette Ehrhardt; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

Review 9.  The human intestinal B-cell response.

Authors:  J Spencer; L M Sollid
Journal:  Mucosal Immunol       Date:  2016-07-27       Impact factor: 7.313

10.  FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.

Authors:  Xing Du; Satoshi Nagata; Tomoko Ise; Maryalice Stetler-Stevenson; Ira Pastan
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.